Aspirin in Pregnancy.

Obstet Gynecol

Division of Maternal-Fetal Medicine, Department of Obstetrics and Gynecology, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina; and the Division of Maternal-Fetal Medicine, Intermountain Healthcare, Salt Lake City, Utah.

Published: December 2023

Preeclampsia is associated with significant perinatal morbidity and mortality. Aspirin has been long purported and extensively studied for prevention of preeclampsia. For this reason, the U.S. Preventive Services Task Force, the American College of Obstetricians and Gynecologists, and the Society for Maternal-Fetal Medicine recommend its use in pregnancy for preeclampsia prevention in those at high risk. Yet, much controversy exists regarding optimal use in pregnancy with guidelines across global organizations varying. In this narrative review, we summarize the published literature related to the safety, optimal dose, and timing and duration of use of aspirin, as well as other indications for which aspirin has been studied in pregnancy.

Download full-text PDF

Source
http://dx.doi.org/10.1097/AOG.0000000000005429DOI Listing

Publication Analysis

Top Keywords

pregnancy preeclampsia
8
aspirin
4
aspirin pregnancy
4
preeclampsia associated
4
associated perinatal
4
perinatal morbidity
4
morbidity mortality
4
mortality aspirin
4
aspirin long
4
long purported
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!